Shlomi nachman biography

Mr.
Mr.
Nachman's distinguished career includes his recent tenure as Johnson & Johnson Company Group Chairman of Cardiovascular & Specialty Solutions.

•

Expanse Medical Welcomes Shlomi Nachman to Board of Directors

PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ -- Expanse Medical, the innovative medical device incubator founded by Eitan Konstantino with focus on global innovations, proudly announces the addition of Shlomi Nachman to its Board of Directors and the Board of its spinoff, Expanse ICE. Mr. Nachman’s distinguished career includes his recent tenure as Johnson & Johnson Company Group Chairman of Cardiovascular & Specialty Solutions and Vision.

As a hub for worldwide medical advancements, Expanse Medical has unwavering commitment to introducing next-generation medical solutions. In tandem with its partner, Genesis Medtech, the incubator remains at the cutting edge of the medical device landscape.

Eitan Konstantino, founder of Expanse Medical, conveyed his excitement, stating, “Our vision has always been to identify and nurture global medical innovations. With Shlomi joining our Board, we are fortifying our pledge. His unmatched experience will undoubtedly push us further in our global pursuits.”

Shlomi Nachman

•

Board of Directors

Mr. Carrel has been President, Chief Executive Officer and director since November 2012. Since joining AtriCure, Mr. Carrel has fostered a patient-first company mission by focusing on the three core areas: innovation, clinical science and education. This strategic approach has led AtriCure to significantly invest in the development of a pipeline of novel products and groundbreaking clinical trials for the treatment of atrial fibrillation (Afib), left atrial appendage management and pain management, and continue to expand its market presence globally. These investments have driven significant growth in AtriCure's revenue from $82 million in 2013 to $399 million in 2023 and allowed us to help over 100,000 patients worldwide in 2023 and one million to date. Further, market cap has increased from $115 million to approximately $1.7 billion at December 31, 2023 under his leadership. In addition, during Mr. Carrel's tenure, AtriCure has acquired three companies, Estech, nContact, and SentreHEART, adding leading ablation and appendage management technologies to fur

•

» Shlomi Nachman

Mr. Nachman has over 25 years of experience in the medical device industry and is currently serving as a board member on a few companies in the medical devices area as well as a board member at the Arnold and Mable Beckman Foundation, a foundation focused on supporting research in chemistry and life sciences.

Previously, he held senior operating roles at Johnson & Johnson, where he was the Company Group Chairman of Cardiovascular and Specialty Solutions and Visions Group within Johnson & Johnson’s Medical Devices sector. He was a member of the Medical Devices Group Operating Committee and led a diverse portfolio of 6 diverse medical device businesses, including Electrophysiology, Neurovascular Intervention, Ear, Nose & Throat, Breast Aesthetics, Optometry, and Ophthalmology. Prior to that, Nachman had various roles with increased scope and responsibilities including Worldwide President of Biosense Webster and Cordis.